The market for Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes is projected to grow at a compound annual growth rate (CAGR) of 9.10% and reach $11.28 billion by 2030. The market is segmented by indication, treatment, end-users, and distribu